Construct-outcome measure | Assessment point | Data type | Effect measure | Tests | |||
T0 | T1 | T2 | T3 | ||||
Screening: (1) Demographic data | x |
|
|
| |||
Primary clinical outcomes: (1) CMDs-SSQ-14 | x | x | x | x |
|
|
|
Secondary clinical outcomes: (1) Depression–PHQ-9, (2) Anxiety–GAD-7, (3) Social support–MPSS, (4) Functioning–WHODAS, (5) HRQoL–EQ-5D-5L, (6) Hope– Herth Hope Index, (7) Resilience–Davison Connor Resilience Scale, (8) therapeutic alliance- WAI-SR | x | x | x | x | Numeric–summative scores | Mean differences | One-way ANOVA repeated measures |
Implementation outcomes: (1) feasibility, (2) uptake/reach, (3) satisfaction, (4) economic/cost | x | x | x | Numeric–summative scores Qualitative |
| t-tests |
ANOVA, analysis of Variance; CMDs, common mental disorders; EQ-5D-5L, EuroQol 5 Dimensions 5 Level; GAD-7, Generalised Anxiety Disorder Assessment; HRQoL, health-related quality of life; PHQ-9, Patient Health Questionnaire; SSQ-14, Shona Symptom Questionnaire; WAI-SR, Working Alliance Inventory-Short Revised (WAI-SR); WHODAS, WHO Disability Assessment Schedule.